HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% cream

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% by

Drug Labeling and Warnings

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% by is a Prescription medication manufactured, distributed, or labeled by Sincerus Florida, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Directions for use

Sincerus Florida, LLC adverse reactions.

Active, inactive

NDC:

72934-2098-2 HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% Cream 30gm

INGREDIENTS AND APPEARANCE

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% 
hyaluronic acid sodium salt 2% / mometasone furoate 0.1% / niacinamide 4% cream

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 72934-2098
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HYALURONIC ACID (UNII: S270N0TRQY) (HYALURONIC ACID - UNII:S270N0TRQY)	HYALURONIC ACID	2 g  in 100 g
MOMETASONE FUROATE (UNII: 04201GDN4R) (MOMETASONE - UNII:8HR4QJ6DW8)	MOMETASONE FUROATE	0.1 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)	NIACINAMIDE	4 g  in 100 g

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72934-2098-2	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/21/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/21/2019

Labeler - Sincerus Florida, LLC (080105003)

Establishment
Name	Address	ID/FEI	Business Operations
Sincerus Florida, LLC		080105003	manufacture(72934-2098)